The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.
Your search for severe asthma returned 397 results
To better understand SABA usage and its implications, investigators examined prescription fulfillment patterns among patients with all levels of asthma severity.
A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.
A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.
No difference seen between dupilumab and placebo groups in adverse events or primary outcome of ventilator-free survival at 28 days
Trial enrolled children from disadvantaged urban neighborhoods who have exacerbation-prone eosinophilic asthma
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Observational study findings highlight a “persistent and marked” association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.
The phase 3 EoE KIDS study included 102 children with active eosinophilic esophagitis based on histologic improvement meeting validated histologic criteria.
The approval was based on data from a phase 3 study that evaluated Dupixent added to low potency topical corticosteroids in children aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.